| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3385553 | Revista Colombiana de Reumatología | 2012 | 11 Pages |
Abstract
improvement was observed with rituximab in SLE-associated hemolytic anemia and thrombocytopenia associated with SLE and antiphospholipid syndrome, who had not responded to first-line therapy. Although LN showed favorable clinical effect and saving allowed dose steroids, prospective studies are required to evaluate utility in patients with LN â¤18.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Immunology, Allergology and Rheumatology
Authors
Andrés Jagua Gualdrón,